Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The European Commission has approved the planned acquisition of Serono by German firm Merck KGaA without any restrictions.
Subscribe to our email newsletter
Merck agreed to buy the Bertarelli family’s 64.5% stake in Serono in September 2006. Merck had originally turned its attention to the acquisition of Serono after it lost out in a bidding war with Bayer for Schering AG earlier in the year.
In the proposed takeover, Merck will buy Serono for $13.31 billion. Merck’s Pharma Ethicals division will be combined with Serono to create Merck-Serono Biopharmaceuticals. The transaction received US antitrust approval in October.